Figure 1.
![PFS based on MRD status (10−5) in MAIA and ALCYONE. Kaplan-Meier estimates of PFS by MRD status among patients in the ITT populations. MRD was assessed at a threshold of 1 tumor cell per 105 white blood cells. Red lines show MRD-negative patient populations and blue lines show MRD-positive patient populations (D-Rd/Rd shown for MAIA [A]; D-VMP/VMP for ALCYONE [B]).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/139/4/10.1182_blood.2020010439/3/bloodbld2020010439f1.png?Expires=1724241941&Signature=2gprcNzM9ee3RYlUIOaBK2Qlp6vdDsrE97vyTa4dctAKMXk0N8yNPAcEIaSQHqsoVwD4~7~Y-7uY6GYf0r4zyd6~zeRsTzuHFGHG5HOjZ51ML8NNocYH9BMXsAw-qMb4iu4e5qDve2dppP4yYsc267yP6FUarblnToegNaNJoWeIXX1ShDFileHxiPFLPMMFSu5WNDCISq2ceRITZqrORyL5~hOyrPsSqvLMXiQJ71HFJ7fBKtAJ5JE~NJWps2795qO5CTh4K2FARSAgrKMAY3CLEE2SpMvjBUcNouicXWbuQov29atmQBy95~cqVbiBz41XD79YvUZC5ghGvWaW5g__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
PFS based on MRD status (10−5) in MAIA and ALCYONE. Kaplan-Meier estimates of PFS by MRD status among patients in the ITT populations. MRD was assessed at a threshold of 1 tumor cell per 105 white blood cells. Red lines show MRD-negative patient populations and blue lines show MRD-positive patient populations (D-Rd/Rd shown for MAIA [A]; D-VMP/VMP for ALCYONE [B]).